Status:
COMPLETED
Combined Use of Povidone-Iodine and Rifampicin in Hair Transplantation
Lead Sponsor:
Elif Asena KANTARCI
Conditions:
Androgenetic Alopecia
Wound Healing
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This randomized controlled clinical trial was designed to evaluate the effectiveness of combining 10% povidone-iodine with 125 mg rifampicin for preoperative scalp antisepsis in hair transplantation p...
Detailed Description
This study was designed to evaluate the effect of the combined use of povidone-iodine and rifampicin for scalp antisepsis in hair transplantation. The study employed a randomized controlled design, in...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Individuals scheduled for hair transplantation surgery
- Fitzpatrick skin type between I and IV
- Willingness to participate and sign the written informed consent form
- Overall health status suitable for the procedure (after preoperative evaluation)
Exclusion
- Presence of active infection, open wound, or dermatological disease at the surgical site
- Systemic infection or immunosuppressive disorders
- Known allergy or sensitivity to povidone-iodine or rifampicin
- Bleeding disorders or current use of anticoagulant therapy
- Pregnancy or breastfeeding
- History of hair transplantation or similar surgical procedure within the last 6 months
Key Trial Info
Start Date :
December 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2022
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT07155408
Start Date
December 2 2021
End Date
June 22 2022
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bahcesehir University, School of Health Sciences, Department of Nursing
Istanbul, Besiktas, Turkey (Türkiye), 34353